Visualize the Future of Precision Medicine with Bio-Techne’s Multiomics Platform: CRC Case Study

Bio-Techne’s multiomics platform provides a comprehensive view of disease by combining genomic data with data from other modalities, including transcriptomics, epigenomics, and proteomics. This approach enables a multifaceted understanding of the molecular changes contributing to disease, allowing researchers to connect genotypes to phenotypes and discover novel drug targets and biomarkers.

A pilot study in colorectal cancer (CRC) screening using the Bio-Techne platform shows the value of integrating multiomic readouts for enhanced CRC classification. The underlying platform can be applied to biomarker signature development and is designed for extension to downstream assay development for clinical trial applications.